Sr Med Director - Hematology/Oncology(Remote U.S)
Thermo Fisher ScientificSalary not specified
- Full Time
- Senior (5 to 8 years)
Bristol-Myers Squibb
Executive Director, Head of Pharmacovigilance - Safety Science
Not SpecifiedCompensation
Senior (5 to 8 years)Experience Level
Full TimeJob Type
UnknownVisa
PharmaceuticalsIndustries
Requirements
Candidates should possess a Bachelor’s degree in Pharmacy, Pharmacology, or a related scientific field, and hold a minimum of 10 years of experience in pharmacovigilance, with at least 5 years in a leadership role. Strong knowledge of global pharmacovigilance regulations, including FDA, EMA, and ICH guidelines, is essential, along with demonstrated expertise in safety data analysis and risk management.
Responsibilities
The Executive Director, Head of Pharmacovigilance - Safety Science will develop and lead the global pharmacovigilance strategy, overseeing safety operations and ensuring compliance with regulatory requirements. They will also direct safety evaluation and risk management for clinical development and post-marketing products, lead the detection and assessment of safety signals, and collaborate with cross-functional teams to support the safe use of products globally.
Skills
Pharmacovigilance
Global Pharmacovigilance Regulations
FDA
EMA
ICH Guidelines
Safety Data Analysis
Risk Management
Safety Signal Detection
Clinical Development
Post-Marketing Products
Bristol-Myers Squibb
Develops and delivers biopharmaceutical medicines
About Bristol-Myers Squibb
Bristol Myers Squibb (BMS) develops and delivers medicines aimed at treating serious diseases, focusing on areas like cancer, autoimmune diseases, and heart conditions. The company conducts extensive research and development to create new drugs, which are sold after receiving regulatory approval. BMS also produces generic drugs, offering affordable alternatives that meet the same quality standards as their branded counterparts. What sets BMS apart from competitors is its dual focus on both innovative and generic medicines, enhancing access to healthcare. The company's goal is to improve patient outcomes while maintaining a commitment to sustainability and corporate responsibility.
Key Metrics
New York City, New YorkHeadquarters
1887Year Founded
$33,706.1MTotal Funding
IPOCompany Stage
Biotechnology, HealthcareIndustries
10,001+Employees